“R.itemList.length” “- this.config.text.ariaShown
“This.config.text.ariaFermé”
(Changes the number of participants in the paragraph to 550 out of 590 after the Ministry of Health has corrected the figures)
MADRID, 28 Ago (Reuters) – Johnson and Johnson’s Janssen unit will begin phase II trials for its COVID-19 vaccine in Spain, the Netherlands and Germany next week, Spanish Health Minister Salvador Illa said Friday as the US drug manufacturer. expands for its experimental success.
The event will last two months and will have 550 participants in the 3 countries, adding another 190 people in Spain, Illa said at a press conference in Madrid.
More than 150 prospective vaccines are being developed and tested internationally to prevent the COVID-19 pandemic, and 30 were added in human trials. To date, there are no coVID-19 vaccines approved, with the exception of a vaccine approved in Russia prior to large-scale trials. (Report through Nathan Allen and Jose Elas Rodroguez; Editing through Bethlehem Carreo)